Analgesia and Dyspnea Protocol
Legal Comments
(Please also read Legal Notices for a more comprehensive disclaimer)
The information provided on the Web site is for Health Care Practitioners and is for informational purposes only. It is not professional medical
advice, diagnosis, treatment or care, nor is it intended to be a substitute therefor.
If you are a Health Care Professional this information is shared with you
on the express condition that you will use your own expertise and
professional judgment in applying any information to a specific
case. This is general information only the validity of which may be
affected by individual patient factors that are unknown to the
author(s).
It is the responsibility of those using this information to ensure
appropriate interpretation and application is undertaken with
regards to any specific clinical situation.
The following protocol for the use of opioids in pain control and dyspnea has been in use
in Winnipeg since 1997, and is a modification of an analgesic protocol used for many years
previously at the St. Boniface General Hospital. It is the responsibility of those using
the information provided here to ensure that appropriate interpretation and application
of the material is undertaken with regards to the specific clinical situation at hand.
If questions please contact:
Mike Harlos MD, CCFP, FCFP
Professor, Faculty of Medicine, University of Manitoba
Medical Director, Palliative Care Sub Program, Winnipeg Regional Health Authority
Medical Director, St. Boniface Hospital Palliative Care
Rm.A8024, 409 Taché Ave,
Winnipeg, Manitoba, Canada R2H 2A6
Ph:1-204-235-3929; Fax:1-204-237-9162; Pager:1-204-932-6231
Email:
mike@harlos.net
Opioid Dosage Chart
| OPIOID |
ROUTE |
DOSAGE STEPS (# mg every 4 hours) |
| Morphine |
po/pr/SL |
5 |
10 |
15 |
20 |
30 |
40 |
60 |
80 |
100 |
130 |
160 |
200 |
240 |
280 |
| SQ |
2.5 |
5 |
7.5 |
10 |
15 |
20 |
30 |
40 |
50 |
65 |
80 |
100 |
120 |
140 |
| Hydromorphone |
po/pr/SL |
1 |
2 |
3 |
4 |
6 |
8 |
12 |
16 |
20 |
26 |
32 |
40 |
48 |
56 |
| SQ |
0.5 |
1 |
1.5 |
2 |
3 |
4 |
6 |
8 |
10 |
13 |
16 |
20 |
24 |
28 |
NOTE: - Generally, in converting from one opioid to another, in order to address incomplete cross-tolerance divide the calculated equivalent dose by half and titrate up quickly if needed.
However, under circumstances of poor pain control it may not be appropriate to reduce the converted dose in this manner.
DETAILS:
- administer a breakthrough medication dose consisting of 50-100% of the q4h dose, up to q1h prn. If more than 3 doses of aggressive breakthrough medications are needed (eg. q1h dosing), the physician should be contacted to review options.
- progress to the next level of the protocol up to once per 24 hours, even without having given prior breakthrough doses.
- change the route of administration as per the protocol table above.
- The patient is drowsy and/or
- The respiratory rate persists between 8-10 per minute. If the respirations are below 8 per minute, the opioid is held and the physician called.
- Patient's respirations are less that 8 per minute;
- Patient's respirations persist between 8-10 per minute in spite of decreasing the opioid dose on the Analgesia and Dyspnea Protocol;
- There are persisting jerking movements, raising the possibility of opioid-induced myoclonus and neurotoxicity;
- The patient is both drowsy and in discomfort;
- The patient requires 3 or more of aggressive breakthrough medication, i.e. every 1 hour dosing;
- The patient develops mental disturbances;
- Dosage has reached the maximum dose on the Opioid Dosage Chart;
- In order to change opioid;
- Any time there is concern about administration of the protocol opioid.
Last Modified Feb. 21, 2003